Application of locked nucleic acids to improve aptamer in vivo stability and targeting function

被引:235
|
作者
Schmidt, KS
Borkowski, S
Kurreck, J
Stephens, AW
Bald, R
Hecht, M
Friebe, M
Dinkelborg, L
Erdmann, VA
机构
[1] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany
[2] Schering AG, Res Labs, D-13342 Berlin, Germany
关键词
D O I
10.1093/nar/gkh862
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aptamers are powerful candidates for molecular imaging applications due to a number of attractive features, including rapid blood clearance and tumor penetration. We carried out structure-activity relationship (SAR) studies with the Tenascin-C binding aptamer TTA1, which is a promising candidate for application in tumor imaging with radioisotopes. The aim was to improve its in vivo stability and target binding. We investigated the effect of thermal stabilization of the presumed non-binding double-stranded stem region on binding affinity and resistance against nucleolytic degradation. To achieve maximal thermal stem stabilization melting experiments with model hexanucleotide duplexes consisting of unmodified RNA, 2'-O-methyl RNA (2'-OMe), 2'-Fluoro RNA (2'-F) or Locked Nucleic Acids (LNAs) were initially carried out. Extremely high melting temperatures have been found for an LNA/LNA duplex. TTA1 derivatives with LNA and 2'-OMe modifications within the non-binding stem have subsequently been synthesized. Especially, the LNA-modified TTA1 derivative exhibited significant stem stabilization and markedly improved plasma stability while maintaining its binding affinity to the target. In addition, higher tumor uptake and longer blood retention was found in tumor-bearing nude mice. Thus, our strategy to introduce LNA modifications after the selection procedure is likely to be generally applicable to improve the in vivo stability of aptamers without compromising their binding properties.
引用
收藏
页码:5757 / 5765
页数:9
相关论文
共 44 条
  • [1] Enhancing aptamer function and stability via in vitro selection using modified nucleic acids
    Meek, Kirsten N.
    Rangel, Alexandra E.
    Heemstra, Jennifer M.
    METHODS, 2016, 106 : 29 - 36
  • [2] The application of locked nucleic acids in the treatment of cancer
    Frieden, Miriam
    Orum, Henrik
    IDRUGS, 2006, 9 (10) : 706 - 711
  • [3] Locked nucleic acids and intercalating nucleic acids in the design of easily denaturing nucleic acids: Thermal stability studies
    Filichev, VV
    Christensen, UB
    Pedersen, EB
    Babu, BR
    Wengel, J
    CHEMBIOCHEM, 2004, 5 (12) : 1673 - 1679
  • [4] Locked nucleic acid/DNA chimeric aptamer probe for tumor diagnosis with improved serum stability and extended imaging window in vivo
    Shi, Hui
    He, Xiaoxiao
    Cui, Wensi
    Wang, Kemin
    Deng, Ke
    Li, Duo
    Xu, Fengzhou
    ANALYTICA CHIMICA ACTA, 2014, 812 : 138 - 144
  • [5] Nucleobase-functionalized Locked Nucleic Acids (LNAs): Optimized probes for nucleic acid targeting
    Hrdlicka, Patrick J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [6] Enhanced inhibition of transcription start by targeting with 2′-OMe pentaribonucleotides comprising locked nucleic acids and intercalating nucleic acids
    Filichev, VV
    Vester, B
    Hansen, LH
    Aal, MTA
    Babu, BR
    Wengel, J
    Pedersen, EB
    CHEMBIOCHEM, 2005, 6 (07) : 1181 - +
  • [7] Application of the Nucleic Acids Based Aptamer Technology into Management of Food Sanitation
    Morita, Yuji
    Fujiwara, Daisuke
    FOOD HYGIENE AND SAFETY SCIENCE, 2014, 55 (06): : J197 - J200
  • [8] The application of click chemistry for targeting quadruplex nucleic acids
    Saha, Puja
    Panda, Deepanjan
    Dash, Jyotirmayee
    CHEMICAL COMMUNICATIONS, 2019, 55 (06) : 731 - 750
  • [9] Combating Hepatitis C Virus by Targeting MicroRNA-122 Using Locked Nucleic Acids
    Machlin, Erica S.
    Sarnow, Peter
    Sagan, Selena M.
    CURRENT GENE THERAPY, 2012, 12 (04) : 301 - 306
  • [10] Targeting metabolic enzyme with locked nucleic acids in non-small cell lung cancer
    Zhang, Wen Cai
    Lim, Bing
    CANCER RESEARCH, 2014, 74 (19)